Ashley Ghiaseddin

Ashley Ghiaseddin, M.D.

Clinical Assistant Professor

Department: MD-NEUROLOGICAL SURGERY
Business Phone: (352) 273-9000

About Ashley Ghiaseddin

Ashley Parham Ghiaseddin, MD, received his B.S. degree from Notre Dame in 2006. He completed his medical degree at the University of Toledo in 2010. He performed his neurology residency at Indiana University, finishing in 2014. Dr. Ghiaseddin then did a neuro-oncology fellowship training at Duke University from 2014-2015. He joined the faculty of the University of Florida department of neurosurgery in 2015.

Dr. Ghiaseddin has multiple peer-reviewed publications and many national presentations. He is an integral part of the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida, dedicated to the cure of malignant brain tumors.

Board Certifications

  • Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Neurosurgery
Areas of Interest
  • Brain tumor – primary – adults
  • Glioblastoma multiforme
  • Headache
  • Metastatic brain tumor
  • Parkinson disease
  • Primary lymphoma of the brain

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0001-5599-4610

Publications

2020
Tumor Treating Fields in the Management of Patients with Malignant Gliomas.
Current treatment options in oncology. 21(9) [DOI] 10.1007/s11864-020-00773-5. [PMID] 32734509.
2020
Introducing a Supportive Care Team for Advance Directive Education in a Neurological and Neurosurgical Patient Population
Journal of Patient Experience. [DOI] 10.1177/2374373520932449.
2020
In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas.
Journal of neuro-oncology. [DOI] 10.1007/s11060-020-03557-x. [PMID] 32757094.
2018
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.
The oncologist. 23(2):157-e21 [DOI] 10.1634/theoncologist.2017-0501. [PMID] 29133513.
2015
Use of bevacizumab in recurrent glioblastoma.
CNS oncology. 4(3):157-69 [DOI] 10.2217/cns.15.8. [PMID] 25906439.

Grants

Sep 2020 ACTIVE
Clinical Development of CAR T Cell Therapy Targeting CD70 in Primary Glioblastoma
Role:
Funding: US ARMY MED RES ACQUISITION

Education

Fellowship – Neuro-oncology
2015 · Duke University
Residency – Neurology
2014 · Indiana University
Internship – Internal Medicine
2011 · Indiana University
Medical Degree
2010 · University of Toledo

Teaching Profile

Courses Taught
2018
BMS6812 Intro Clin Med 2

Contact Details

Phones:
Business:
(352) 273-9000